NewAmsterdam Pharma Company
NAMS
#4234
Rank
ยฃ2.23 B
Marketcap
ยฃ19.13
Share price
-3.32%
Change (1 day)
7.86%
Change (1 year)

Earnings for NewAmsterdam Pharma Company (NAMS)

Earnings in 2026 (TTM): -ยฃ0.17 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's current earnings are ยฃ22.56 Million. In 2025 the company made an earning of -ยฃ0.17 Billion, an increase over its 2024 earnings that were of -ยฃ0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NewAmsterdam Pharma Company from 2023 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.17 Billion-3.98%
2025 -ยฃ0.17 Billion-7.81%
2024 -ยฃ0.19 Billion38.38%
2023 -ยฃ0.14 Billion